bioassay/AID2547

Predicate	Object
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/NCGC
title	Secondary Assay for Inhibitors of Human Galactokinase (GALK): HEK-293 Cell Viability Assay
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID2547
has assay stage	http://www.bioassayontology.org/bao#BAO_0000030
is confirmatory assay of	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID2502 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID2506 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID493188 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1868 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID2114 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID2499
type	http://www.bioassayontology.org/bao#BAO_0000015

Predicate	Subject
is confirmatory assay of	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID493188 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1868 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID2506 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID2499 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID2502
is summary assay of	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID2114

Total number of triples: 17.